FDA Reorganization To Focus On Employee Specialization
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency’s Program Alignment Group recommends “commodity-based and vertically-integrated programs” to improve efficiency and communication.
You may also be interested in...
Pharma Import Alert: FDA Working Towards Consistency, Better Decision Making
FDA’s broad reorganization may not create the same super-specialization for the import staff that is coming to other parts of the agency, but a process overhaul appears on its way regardless.
FDA Launches Global Rx Quality Initiative With Plans To Rely On Non-U.S. Regulators
Agency restructures staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality but offers few details on upcoming plans.
Mylan Grabs More FDA Globalization Talent
Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.